Risks associated with Cyclosporine and COVID-19
Cyclosporine is part of immunosuppressive therapy. It is advised to
administer Cyclosporine with corticosteroids in organ transplant
patients. It increases risk for infection and lymphoma formation. Due to
the current COVID-19 pandemic, it is advised to significantly reduce the
dose of certain immunosuppressive agents wherein patients who are heart,
liver or kidney transplant recipients are exposed to the virus. For
outpatients, they can continue the dose as recommended to avoid frequent
visits to the doctor [26-27].